baber/WOPTO huggingface dataset:
Patent CA-2372028-A1 (CA)
Title: Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
Inventor: STINCHCOMB DAN T
IPC: C12Q1/68
Filed: 2000-04-07
Abstract: The present invention relates to flea head, nerve cord, hindgut and malpighian tubule proteins; to flea head, nerve cord, hindgut and Malpighian tubule nucleic acid molecules, including those that encode such flea head, nerve cord, hindgut and Malpighian tubule proteins; to antibodies raised against such flea head, nerve cord, hindgut and Malpighian tubule proteins; and to compounds that inhibit flea head, nerve cord, hindgut and Malpighian tubule protein activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising proteins, nucleic acid molecules, or protective compounds derived from proteins of the present invention as well as the use of such therapeutic compositions to protect animals from flea infestation. Also included in the present invention is the use of flea head, nerve cord, hindgut and Malpighian tubule proteins to derive inhibitory compounds.
Patent CA-2375517-A1 (CA)
Inventor: SOBEL WILLIAM E
IPC: G06F17/30
Filed: 2000-06-15
Abstract: A file stored on a storage media can be updated even while it is being accessed by an application and without requiring a reboot. In one embodiment  of the invention a file stored on a storage media, having a file name listed  in a directory, is updated by placing an updated version of the file on the storage media. A listing for the updated version of the file is added to the  directory under a temporary name. The original file name listed in the directory is changed to a different name, and the temporary name is changed to the former name of the original file.
Patent CA-2375527-A1 (CA)
Title: Procede destine a promouvoir l'hematopoiese
Inventor: FLEMING WILLIAM H
IPC: A61K35/44
Filed: 2000-06-22
Abstract: L'invention concerne un procédé destiné à promouvoir l'hématopoïèse et consistant à transplanter, sur un sujet, au moins une portion efficace sur le plan thérapeutique d'un tissu vasculaire isolé, de manière que ce tissu vasculaire favorise l'hématopoïèse; elle concerne également un procédé de détection d'un agent agissant sur l'hématopoïèse, consistant à transplanter sur un sujet une portion d'un tissu vasculaire isolé, de manière que cette portion de tissu soit suffisante pour promouvoir l'hématopoïèse. On traite le tissu vasculaire à l'aide d'un agent, on détecte l'hématopoïèse chez le sujet, et on compare cette hématopoïèse avec celle d'un témoin, un changement dans l'hématopoïèse du sujet par rapport au témoin indiquant que l'agent agit sur l'hématopoïèse. L'invention concerne encore une technique d'isolation d'un facteur de croissance hématopoïétique, ainsi qu'une technique d'isolation d'une cellule souche hématopoïétique, dans lesquelles on utilise le procédé de l'invention. L'invention concerne en outre des compositions pharmaceutiques et des trousses destinées à promouvoir l'hématopoïèse, ainsi qu'un modèle animal non humain servant à l'essai des agents agissant sur l'hématopoïèse. Ce modèle est un animal non humain présentant une carence de type hématopoïétique et sur lequel on a transplanté une portion isolée d'un tissu vasculaire, suffisante pour promouvoir l'hématopoïèse.
Patent CA-2376305-A1 (CA)
Inventor: LINDSTROM KYLE J
IPC: A61K45/06
Filed: 2000-06-08
Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain sulfonamide or sulfonamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
Patent CA-2377796-A1 (CA)
Title: Electrode
Inventor: HILL ANDREW
IPC: C25B11/02
Filed: 2000-07-03
Abstract: An electrode comprises an elongate hollow tube (5) made of porous titanium suboxide the inside wall of which is contacted at spaced apart locations by an electrical conductor (11, 12) so that the current is substantially uniformly distributed along the length of the electrode.
Patent CA-2379639-A1 (CA)
Inventor: FAZAKAS ANDRAS
IPC: G01R19/00
Filed: 2000-07-03
Abstract: A method and electronic circuit for detecting slow and small changes of electrical signal including the sign of the changes, comprising the steps of switching the signal to be detected periodically to a capacitor and changing thereby its charge state taken in the previous period, examining the extent and sign of the decaying current pulse caused when said capacitor has been forced to take the new charge state, if the extent of this decaying current pulse is higher than a predetermined threshold limit, storing this fact and the sign of the change till the next period.
Patent CA-2380231-A1 (CA)
Title: Conditionally controlled, attenuated hiv vaccine
Inventor: SMITH STEPHEN
IPC: A61K39/00
Filed: 2000-07-25
Abstract: The present invention provides an attenuated HIV vaccine comprising an HIV virus modified to replicate only in the presence of at least one tetracycline analogue. Additionally, the present invention provides a method for immunization of humans against HIV which comprises administering to a human a vaccine including an HIV virus modified to replicate only in the presence of at least one tetracycline analogue.  Simultaneously, at least one tetracycline analogue is administered for a period of time to allow replication of the modified HIV virus in vivo sufficient to produce immunity. Preferably, the tetracycline analogue is doxycycline. A replication competent HIV-DoxT virus genome which can be controlled by the presence or absence of doxycycline is produced by preparing a promoter, TetopTCAT;  producing a provirus, pHIV-DoxT, using the TetopCAT promoter, and transfecting the pHIV-DoxT in cell lines in the presence of doxycycline. A replication competent HIV-DoxSp virus genome which can be controlled by the presence or absence of doxycycline is produced by preparing a promoter, TetopSpCAT; producing a provirus, pHIV-DoxSp, using the TetopCAT  promoter, and transfecting the pHIV-DoxSp in cell lines in the presence of doxycycline. Anti-HIV vaccines are prepared using the HIV-DoxT and HIV-DoxSp virus genomes.  These viruses and doxycycline are administered to human hosts. The doxycycline is administered for a time sufficient to build up immunity and then the administration of the drug is stopped so that the doxycycline-dependent viruses will no longer replicate.
Patent CA-2380279-A1 (CA)
Title: Flexible seal forming member
Inventor: MCKENRICK TIMOTHY D
IPC: F16L5/02
Filed: 2001-05-21
Abstract: A seal apparatus (11) including an elongated body (22) formed of a resilient  expandable material defining an interior chamber (24) and having a longitudinal axis (26). The elongated body is capable of being rolled up on itself by rolling one of the first and second ends (30A, 30B) of the elongat ed body in a direction parallel to the longitudinal axis. At least one stem (34 ) is attached to the elongated body and is in fluid communication with the interior chamber.
Patent CA-2381562-A1 (CA)
Inventor: MORONEY PAUL
IPC: H04N7/26
Filed: 2000-08-16
Abstract: A consumer set-top terminal (400) and method that receives and stores digital programming services such as television programs for subsequent playback by the user in a manner analogous to a conventional video cassette recorder (VCR). An interface (480) allows the terminal's user to control a transcoding process (427) based on the desired quality level for the transcoded data, e.g., high, medium or low. The transcoding is provided without the expense and complexity of a full encoder. By performing transcoding at the terminal (400), the bit rate of the data can be reduced sufficiently to allow economical storage at the terminal. Moreover, the user can set the quality level to be different for different programs, different parts of the same program, or for different channels.
Patent CA-2381956-A1 (CA)
Title: Method of disposal of pet waste
Inventor: MITCHELL CARL
IPC: A01K1/01
Filed: 2002-04-17
Abstract: A method of collecting excrement of pets such as dogs and cats and disposing of it in an environmentally acceptable manner, The method involves the steps of:  providing a number of receptacles for excrement in a household containing pets, a park and wherever else there are pets accompanied by humans. Receptacles containing excrement are periodically collected and transported to a facility for disposal. At the facility the excrement is disposed of by flushing it into the sewer where that is legal or by composting by means of worms, larvae, micro-organisms, heat or the combination of heat, wind and rain.
Patent CA-2382380-A1 (CA)
Title: Method for altering function of electronic apparatus, customer center, dealer system, and user system
Inventor: YAMAMOTO SEIICHI
IPC: H04M15/00
Filed: 2001-06-20
Abstract: When a new function is added to a button telephone (BT), a function addition request is transmitted from a user PC of a user system CM to a customer center (CC). The function addition request includes information indicative of a function to be added, a credit number, and the telephone number of the button telephone. The customer center (CC), accesses a credit company (CR) by using the received credit number, and the credit of the user is inspected. The button telephone (BT) of the user is accessed by using the telephone number through a public network (PNW) to acquire the function information of the button telephone (BT). It is judged whether the function can be added or not based on the function information. If the function can be added, a license code of the additional function is delivered to the button telephone (BT) of the user through the public network (PNW), and the function is added.
Patent CA-2382558-A1 (CA)
Title: Method of markup language accessing of host systems and data using a constructed intermediary
Inventor: MURPHY GARY L
IPC: G06F40/143
Filed: 2000-08-29
Abstract: A method of operating and communicating with a host system (12) is provided using mark-up language (18) inputs and outputs directed by an intermediary (10) which has been previously constructed by formulation of the host data and program structures and host machine characteristics into a system of metadata which allows the reconstruction of requests and results into and out of mark-up languages binary data streams.
Patent CA-2382970-A1 (CA)
Title: Cosmetic based on oligomers and polymers containing urethane and/or urea functional group
Inventor: NGUYEN KIM SON
IPC: A61K8/00
Filed: 2000-08-30
Abstract: The invention relates to oligomers and polymers with urethane- and/or ureas and other functional groups, utilization of said oligomers and cosmetics which contain said oligomers and polymers.
Patent CA-2383160-A1 (CA)
Inventor: BOILY SABIN
IPC: C03C14/00
Filed: 2002-04-24
Abstract: The invention relates to a method of producing an optical glass precursor in powder form containing nanocrystals. The method of the invention comprises subjecting a glass material and an optically active crystalline material to high-energy ball milling to obtain a composite material in powder form comprising particles each containing nanocrystals of the optically active crystalline material uniformly dispersed in a matrix of the glass material, the composite material defining the aforesaid optical glass precursor. Such a method enables the composition of the nanocrystals to be varied independently of the composition of the glass matrix.
Patent CA-2384185-A1 (CA)
Inventor: ROMANUFA KERILEY K
IPC: G06F12/08
Filed: 2002-04-29
Abstract: A hash table is provided in which identifying properties of the data items pointed to by the hash table are selected and are included within the hash table buckets.  The properties recorded in the buckets are able to be stored in a cache for the hash table and are used to located data items pointed to by the hash table. The hash table has bucket groups defining a second level hash table. The bucket groups are used to permit resizing of the hash table.  Each bucket group has a latch so that that exclusive access for the resizing operation is obtainable on a group by group basis.
Patent CA-2384525-A1 (CA)
Inventor: DE BARREIRO ELIEZER J
IPC: A61P9/04
Filed: 2000-06-21
Abstract: The invention discloses a compound having the formula (I) wherein R1 is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms, unsubstituted phenyl, and substituted phenyl; R2 is selected from the group consisting of H, alkene, un-substituted phenol, and substituted phenyl; and pharmaceutically acceptable salts thereof, having digitalis-like properties. The invention further discloses a novel method to synthesize 3,4-methylenedioxyben-zoyl-2-thienylhydrazone (LASSBio-294). LASSBio-294 produces positive inotropic effect on cardiac and skeletal muscle. The invention is useful for the treatment of congestive heart failure and muscle fatigue. It lacks toxic effects seen in digitalis glycosides.
Patent CA-2387986-A1 (CA)
Title: Desulfurization and novel sorbents for same
Inventor: KHARE GYANESH P
IPC: C10G25/00
Filed: 2000-10-18
Abstract: Particulate sorbent compositions which are suitable for the removal of sulfur from streams of cracked-gasoline or diesel fuel are provided which have increased porosity, improved resistance to deactivation through the addition of a calcium compound selected from the group consisting of calcium sulfate, calcium silicate, calcium phosphate or calcium aluminate to the support system comprised of zinc oxide, silica and alumina having thereon a promotor wherein the promotor is metal, metal oxide or metal oxide precursor with the metal being selected from the group consisting of cobalt, nickel, iron, manganese, copper, molybdenum, tungsten, silver, tin and vanadium or mixtures thereof and wherein the valence of such promotor has been substantially reduced to 2 or less. Process for the preparation of such sorbent systems as well as the use of same for the desulfurization of cracked-gasolines and diesel fuels are also provided.
Patent CA-2394458-A1 (CA)
Title: Procedes de production de dispositifs de circuits integres encapsules et dispositifs de circuits integres encapsules ainsi produits
Inventor: BADEHI AVNER PIERRE
IPC: H01L23/02
Filed: 2000-11-26
Abstract: L'invention concerne un dispositif à base de substrat cristallin comportant un substrat cristallin (102) sur lequel est formé une microstructure (100); et au moins une couche d'encapsulation (106) scellée sur la microstructure au moyen d'un adhésif et y définissant au moins un espace entre le substrat cristallin (102) et ladite couche (106). L'invention concerne enfin un procédé de production d'un dispositif à base de substrat cristallin.
Patent CA-2395635-A1 (CA)
Inventor: ALIBERT JEAN-MARIE G
IPC: G02B6/13
Filed: 2000-12-13
Abstract: A method of forming a hybrid optical component includes the steps of masking and etching a pattern on a core layer of a planar optical component to define at least one alignment element and an optical element and subsequently overcladding the optical element such that a passive platform is formed which exposes a surface of the optical element such as a waveguide and an alignment element for receiving a mirror image alignment element formed on an active platform including an active device, such as a laser. Hybrid components include a passive platform having an alignment element formed therein and a waveguide for receiving an active platform with a mating mirror image alignment element and an active device which aligns with the waveguide when the platforms are mated. Such a fabrication method and resulting optical component provide a highly efficient, self-aligning passive and active component platforms which greatly reduce the cost of fabrication of hybrid optical circuits as well as improve their reliability and reduce their cost.
Patent CA-2396030-A1 (CA)
Inventor: MANIKUMAR GOVINDARAJAN
IPC: A61P35/02
Filed: 2000-06-14
Abstract: .beta.-Alanine esters of camptothecin compounds having the structure:     which are effective anti-tumor compounds are disclosed. These compounds inhibit the enzyme topoisomerase I and may alkylate DNA of the associated topoisomerase I-DNA cleavable complex.
Patent CA-2398105-A1 (CA)
Inventor: KWIECIEN MICHAEL J
IPC: B26B21/44
Filed: 2001-02-06
Abstract: The present invention is directed to a razor cartridge (14) with a solid poly-meric shaving aid strip (22). The razor cartridge has a blade (18) (one or more) and a skin-engaging portion in proximity of the blade. The skin-engaging portion includes a solid polymeric shaving aid strip (22) having an upper exposed surface which contacts the skin during shaving.  The shaving aid strip includes a first exposed lengthwise-extending portion (24) containing a lubricous water-soluble polymer and an adjacent, second exposed lengthwise-extending portion (26) containing a lubricous water-soluble polymer. The first portion contains a greater amount of the lubricous water-soluble polymer than the second portion, and the first portion is adapted to wear at a faster rate than the second portion during shaving.  This construction enables the strip to release more of the lubricous water-soluble polymer for a longer time pe-riod (i.e., for more shaves) than conventional shaving aid strips.
Patent CA-2401196-A1 (CA)
Inventor: PATRICK JAMES T
IPC: B65G39/09
Filed: 2002-09-03
Abstract: The invention is particularly useful for coacting with roller tubes of conveyor apparatus. A cartridge bearing including a stub axle with a tip of greater hardness than the surface circumscribing the aperture receiving the stub axle is inserted into an end of a conveyor roller tube. Along with being electrically conductive, the stub axle can be provided with a damper for reducing vibration. The stub axle engages an electrically conductive stub shaft and moves axially with respect to the stub shaft to operatively interlock with the aperture of the fixed structure. Use of the cartridge bearing provides for the grounding of static charge that can accumulate during operation of conveyor roller tubes.
Patent CA-2405752-A1 (CA)
Title: Apparatus and method for controlling liquor circulation flow in long vertical shaft bioreactors
Inventor: POLLOCK DAVID C
IPC: C02F3/22
Filed: 2001-05-09
Abstract: This application relates to improvements to long vertical shaft bioreactors for the aerobic biological treatment of wastewater and aerobic digestion of biodegradable sludges. The invention comprises a flow control device (100) and method which improves hydraulic flow, inter-zonal mixing and gas transfer in such bioreactors. The flow control device (100) includes a ported upper plate (102) which is mounted in an upflow chamber (24) of the bioreactor and a lower plate (104) located below the upper plate (102) at the jucture between mix and plug flow zones of the bioreactor (102) which are in fluid communication.      At least some of the ports (108) in the upper plate (102) are fitted with adjustable valves (110) for regulating the flow of liquor therethrough and hence the size of a hydraulic head loss imposed by the flow control device (100). Preferably the upper plate (102) is mounted at a location in the upflow chamber (24) upstream from the inlet (30) where influent is discharged into the bioreactor (10). The flow control device (100) reduces the circulation velocity of the liquor in an upper circulating zone of the bioreactor and also provides a physical burner substantially restricting inter-zonal mixing between the mix (D) and plug flow zones.
Patent CA-2410635-A1 (CA)
Title: Infusion of liquids into the human or animal body
Inventor: MAKKINK ANDREW EUGENE
IPC: A61M5/00
Filed: 2001-05-25
Abstract: An infusion device (310) includes an upstream pressure control device (344) and a downstream flow control device (320). The device (344) receives infusion liquid via an inlet (348) and controls the level of liquid in a chamber (346) by means of a float (350) which can close both the inlet (348) and an outlet (368). A filtered vent (362) maintains atmospheric pressure in the chamber (346). The device (320) receives infusion liquid at constant head via a flow pipe (316.1). A dripper (341) delivers droplets into an airtight chamber (324). A taper needle (330) renders an orifice (328) adjustably open to a desired degree to deliver liquid at a selected rate. Screw threaded adjustment (336) and calibration means allow calibrated adjustment. A flow pipe (316) delivers a metered flow of infusion liquid for infusion into a human or animal body.
Patent CA-2410995-A1 (CA)
Inventor: HESSEL HANS
IPC: A61F11/00
Filed: 2000-09-25
Abstract: The invention relates to an otoplastic with a housing forming an outer surface with characteristic projections and recesses formed thereon and a method for production of such an otoplastic, in particular for the manufacture of hearing aids.
Patent CA-2413264-A1 (CA)
Title: Medical instrument for use with liquids
Inventor: BESEK MARIO
IPC: A61C5/04
Filed: 2002-12-02
Abstract: The medical instrument for the application of liquids to teeth includes a handle portion and a treating portion, the treating portion comprising a highly elastic sponge. In a preferred embodiment, the treating portion is connected to the handle portion by a ball joint. The use of a sponge allows an optimum application of the liquid on and in cavities without leaving residual material. The presence of a ball joint allows a safe treatment also in locations that are difficult to access otherwise.
Patent CA-2414547-A1 (CA)
Inventor: FLIPO BERNARD
IPC: A61B10/02
Filed: 2001-07-02
Abstract: The invention concerns a clamp for medical use comprising two pivotably articulated jaws controlled by the practitioner from a gripping zone. The invention is characterised in that one (7) of the jaws (7, 8) comprises means for tacking the patient's tissues projecting outwards of the clamp; one (7) of the jaws (7, 8) has two cutting edges (10) on its periphery to cut the tissues; at least one of the jaws (7, 8) comprises a cavity (13) for receiving the cut tissues.
Patent CA-2414753-A1 (CA)
Title: Systeme therapeutique dermique contenant de l'acide 2-(3-benzophenyl)-propionique ou de l'acide [0-(2,6-dichloranilino)-phenyl]-acetique
Inventor: VOLLMER ULRIKE
IPC: A61K31/195
Filed: 2001-07-05
Abstract: L'invention concerne un système thérapeutique dermique comprenant une couche de recouvrement, une matrice collante ayant une teneur en acide 2-(3-benzophényl)-propionique ou en acide [o-(2,6-dichloranilino)-phényl]-acétique ou un de leurs dérivés usuels en pharmacie comme principe actif et une couche de protection amovible. Ce système est caractérisé en ce que la matrice collante est un copolymère d'acrylate.
Patent CA-2414929-A1 (CA)
Title: Bedside lower extremity lifting apparatus
Inventor: PERLA FRANK W
IPC: A47C19/04
Filed: 2002-12-20
Abstract: A bedside lower extremity lifting apparatus is comprised of a support frame coupled to a platform. The support platform can be selectively raised and lowered by an actuator assembly coupled between the support frame and the platform. The lifting apparatus is configured to be positioned adjacent a conventional patient support structure such as a mattress-type bed or patient table and can be properly used and operated in conjunction with the bed with or without modification thereto. When the platform is in its lowered position, the platform and support frame have a relatively low profile so as to allow a user to comfortably sit on the edge of the bed. A user control is provided to allow the user to selectively raise and lower the platform as desired. By sitting on the edge of the bed and raising the platform to a sufficiently elevated position, the user is able to raise his or her legs to a height that allows the user to more comfortably maneuver their legs onto the bed.